Identification and validation of genes associated with prognosis of cisplatin-resistant ovarian cancer
VPS13B, TBC1D22A, PPP3CA, CUX1 and PPP1R15A were identified as poor prognostic genes of cisplatin resistance in ovarian cancer, while PLGRKT, CDKAL1 and TAP1 were identified as good prognostic genes. This offers a novel perspective for future advancements in ovarian cancer treatment, suggesting potential avenues for the development of new therapeutic targets.
Authors
- Ruiyun Li (ORCID: https://orcid.org/0000-0001-8927-9965)
- Dajiang J. Liu (ORCID: https://orcid.org/0000-0001-6553-858X)
- Yidan Wang (ORCID: https://orcid.org/0000-0002-7372-4160)
- Leilei Li (ORCID: https://orcid.org/0000-0001-8161-2559)
- Dan Li
Institutions
- First Hospital of Lanzhou University (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1186/s12885-024-12264-z
- Citations
- 3
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Lanzhou University
- National Natural Science Foundation of China